Growing bent towards detecting the toxicity during initial stages of production is driving the in-vitro toxicity testing market in pharmaceutical sector. Whereas, support from regulatory authorities for using in-vitro and in-silico methods for studying toxicity of a substance is driving the in-vitro toxicity testing market in cosmetic industry. On the basis of methods, the global in-vitro toxicity testing market can be segmented into biochemical assays, cellular assays, in-silico and ex-vivo. Of these, cellular assays dominate the global in-vitro toxicity testing market. Cellular assays are used as bio markers. In addition, they are used to study about the biological properties of the potential drug compounds.
A sample of this report is available upon request @ www.persistencemarketresearch.com/samples/3587
On the basis of applications, systemic toxicity testing is the largest segment in the global in-vitro toxicity testing market. Europe, followed by the North America dominates the global in-vitro toxicity testing market due to technological advancement and increased R&D initiatives in the region. In addition, government initiatives such as passing of anti-animal testing laws and more awareness among the people are some of the major factors driving the in-vitro toxicity testing market. Asia is expected to experience high growth rate in the next few years in in-vitro toxicity testing market. China and India are expected to be the fastest growing in-vitro toxicity testing markets in Asian region. This is due to large investment by various major companies in these countries. Some of the key driving forces for in-vitro toxicity testing market in emerging countries are rising government funding and growing awareness about new technologies.
Some of the major factors that are driving the in-vitro toxicity testing market are increasing acceptance by regulatory authorities for using in-vitro toxicity testing methods. In addition, factors such as advancement in the field and government initiatives are driving the global market for in-vitro toxicity testing. However, technological disadvancements linked with limiting the use and decreasing adoption rate are restraining the driving the global market for in-vitro toxicity testing. In addition, inability of in-vitro models to detect auto immunity and immunostimulation are restraining the global market for in-vitro toxicity testing.
Rising demand for in-vitro techniques, increasing drug discovery and innovations are expected to offer good opportunities for the global market for in-vitro toxicity testing. However, reluctance of regulatory authorities for using in-vitro toxicity testing methods and validation of new in-vitro method are some of the challenges faced by the global market for in-vitro toxicity testing. One of the latest trends that have been observed for the global in-vitro toxicity testing market includes shifting focus to innovative approaches of 3d cell culture.
To view TOC of this report is available upon request @ www.persistencemarketresearch.com/toc/3587
Some of the major companies dealing in the global in-vitro toxicity testing market are Agilent Technologies, Alere, Inc., Bio-Rad, BioReliance (Sigma Aldrich), GE Healthcare and Quest Diagnostics. Some other companies having significant presence in the global in-vitro toxicity testing market includes Catalent Pharma Solutions, Life Technologies Corporation (Thermo Fisher Scientific), Charles River Laboratories and Covance.
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353